文献速递淋巴瘤

自分泌LTA信号驱动霍奇金淋巴瘤NF-κB与JAK-STAT活性及髓系基因表达

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
PubMed 文献 · Blood · 2019-01-29

研究通过色谱与质谱分析培养的经典型霍奇金淋巴瘤(cHL)细胞分泌组,鉴定淋巴毒素-α(LTA)为自分泌和旁分泌激活NF-κB的因果因子。LTA还促进JAK2/STAT6信号,并受非经典NF-κB转录激活形成反馈环路,驱动包括CSF2、CD40、PD-L1/PD-L2、VCAM1等基因表达。LTA诱导淋巴系与髓系谱系相关基因,作者认为靶向LTA可为cHL治疗策略提供依据。

要点

  • LTA是cHL细胞系自分泌和旁分泌激活经典与非经典NF-κB的因果因子。
  • LTA促进JAK2/STAT6信号,并与非经典NF-κB形成持续反馈环路。
  • LTA诱导淋巴系和髓系谱系相关基因表达,影响微环境相互作用和谱系模糊性。

核心结论

  • LTA维持自分泌NF-κB激活,影响多条信号通路活性,并驱动微环境相互作用和谱系模糊性相关基因表达。
  • 作者认为这些数据为靶向LTA作为cHL患者治疗策略提供了有力依据。

研究设计与样本

  • 研究采用无偏倚方法,通过色谱和随后的质谱分析培养的cHL细胞分泌组,以鉴定cHL细胞分泌的NF-κB激活关键因子。

主要发现

  • 鉴定出淋巴毒素-α(LTA)是cHL细胞系中自分泌和旁分泌激活经典与非经典NF-κB的因果因子。
  • LTA除诱导NF-κB外,还促进JAK2/STAT6信号。
  • LTA及其受体TNFRSF14由非经典NF-κB转录激活,形成持续反馈环路。
  • LTA塑造细胞因子、受体、免疫检查点配体和黏附分子的表达,包括CSF2、CD40、PD-L1/PD-L2和VCAM1。
  • 与人造血细胞单细胞基因活性谱比较显示,LTA诱导淋巴系限制性基因以及主要局限于髓系的基因。

临床怎么用

  • 作者认为这些数据为靶向LTA作为cHL患者治疗策略提供了有力依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Persistent NF-κB activation is a hallmark of the malignant Hodgkin/Reed-Sternberg (HRS) cells in classical Hodgkin lymphoma (cHL). Genomic lesions, Epstein-Barr virus infection, soluble factors, and tumor-microenvironment interactions contribute to this activation. Here, in an unbiased approach to identify the cHL cell-secreted key factors for NF-κB activation, we have dissected the secretome of cultured cHL cells by chromatography and subsequent mass spectrometry. We identified lymphotoxin-α (LTA) as the causative factor for autocrine and paracrine activation of canonical and noncanonical NF-κB in cHL cell lines. In addition to inducing NF-κB, LTA promotes JAK2/STAT6 signaling. LTA and its receptor TNFRSF14 are transcriptionally activated by noncanonical NF-κB, creating a continuous feedback loop. Furthermore, LTA shapes the expression of cytokines, receptors, immune checkpoint ligands and adhesion molecules, including CSF2, CD40, PD-L1/PD-L2, and VCAM1. Comparison with single-cell gene-activity profiles of human hematopoietic cells showed that LTA induces genes restricted to the lymphoid lineage, as well as those largely restricted to the myeloid lineage. Thus, LTA sustains autocrine NF-κB activation, impacts activation of several signaling pathways, and drives expression of genes essential for microenvironmental interactions and lineage ambiguity. These data provide a robust rationale for targeting LTA as a treatment strategy for cHL patients.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. von Hoff L, Kärgel E, Franke V, et al. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma. Blood. 2019. PMID: 30696620. doi:10.1182/blood-2018-08-871293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。